Press release
Carbapenem-resistant Enterobacteriaceae Testing Market Projected to Witness Vigorous Expansion by 2018-2028
Carbapenem-resistant Enterobacteriaceae Testing
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea testing market have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing market is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2268
Carbapenem-resistant Enterobacteriaceae Testing Market: Drivers
People admitted to any healthcare setting for medical care are more prone to infection and to go for Carbapenem-resistant enterobacteriaceae testing than healthy people. Increase in the number of people requiring inpatient medical assistance, growing number of healthcare facilities, increased number of complex surgeries, multiple use of several antibiotics and rise in use of medical devices in the body, such as urinary catheters, intravenous catheters and ventilators, are few of the major factors responsible for growth in the Carbapenem-resistant enterobacteriaceae testing market. Growing awareness about prevention of Carbapenem resistance and increased efforts by governments through the implementation of infection prevention and control measures might hinder the growth of the Carbapenem-resistant enterobacteriaceae testing market during the forecast period.
Carbapenem-resistant Enterobacteriaceae Testing Market: Segmentation
Based on test type, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
Minimal inhibitory concentration Carbapenem-resistant Enterobacteriaceae Testing
Other types of Carbapenem-resistant Enterobacteriaceae Testing
Based on end users, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
Hospitals
Ambulatory Surgical Centers
Intensive Care Units
Clinics
Nursing Homes
Long Term Acute Care Centers
Others
Get Access to Report @ https://www.factmr.com/checkout/2268/S
Based on geography, the global Carbapenem-resistant Enterobacteriaceae Testing Market is segmented as:
North America
Latin America
Europe
CIS & Russia
Japan
APEJ
Middle East & Africa
Carbapenem-resistant Enterobacteriaceae Testing Market: Overview
In Carbapenem-resistant Enterobacteriaceae Testing, Modified Hodge tests are anticipated to be one of the leading test types for Carbapenem-resistant enterobacteriaceae testing because of high accuracy of test results. These tests are easy to perform and can be performed in a routine laboratory, which makes them more feasible and thus, one of the leading test types in Carbapenem-resistant enterobacteriaceae testing market. Molecular testing detects the resistance mechanism whereas phenotypic tests detect the in-vitro activity of carbapenemase enzyme. Healthcare settings, such as nursing homes and acute care centers, where constant medical care is required for a longer duration of time are more prone to CRE and thus, the demand for Carbapenem-resistant enterobacteriaceae testing is higher in these settings.
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2268
Carbapenem-resistant Enterobacteriaceae Testing Market: Regional Outlook
According to The Centers for Disease Control and Prevention (CDC), by 2013 Carbapenem-resistant enterobacteriaceae was found in almost 42 states. CDC also stated that enterobacteriaceae proportion of Carbapenem-resistance has consistently increased and has increased four-fold in the past ten years. During the early 2000s, CRE was rare in the North America region. However, the breakout of CRE in the northeast spread through the US, thereby boosting the market for Carbapenem-resistant enterobacteriaceae testing in the region. The Asia-pacific market for Carbapenem-resistant enterobacteriaceae testing is also expected to expand during the forecast period because of detection of different classes of carbapenemase.
Carbapenem-resistant Enterobacteriaceae Testing Market: Key Players
Some of major participants operating in the Carbapenem-resistant Enterobacteriaceae Testing market are TBA, SolGent Co., Ltd., ELITechGroup, ALIFAX S.r.l. and bioMérieux, Inc.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Download Free Brochure@ https://www.factmr.com/connectus/sample?flag=B&rep_id=2268
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LATAM
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. Etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Overview @ https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carbapenem-resistant Enterobacteriaceae Testing Market Projected to Witness Vigorous Expansion by 2018-2028 here
News-ID: 1446806 • Views: …
More Releases from Fact.MR
Global Waxy Maize Starch Market Set for 6.1% CAGR Surge, Projected at USD 7.7 Bi …
The waxy maize starch market is projected to be valued at USD 4.3 billion in 2025. According to a research study by Fact.MR, the market is expected to grow at a compound annual growth rate (CAGR) of 6.1%, reaching USD 7.7 billion by 2035.
The waxy maize starch market has seen significant growth due to the increasing demand for specialty starches in various food, beverage, and industrial applications. Waxy maize starch…
Tracheal Stents Industry Poised for USD 281 Million Valuation by 2035 with 8.4% …
The tracheal stents market is expected to be valued at USD 126 million in 2025. According to Fact.MR research, the market will grow at a robust compound annual growth rate (CAGR) of 8.4%, reaching USD 281 million by 2035.
The tracheal stents market has been gaining considerable attention due to the increasing prevalence of respiratory disorders and the rising need for advanced medical interventions. Tracheal stents are medical devices used to…
Global Sustained Release Excipients Market Forecasted to Reach USD 3.45 Billion …
The global sustained release excipients market is projected to reach USD 1.58 billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2035, ultimately reaching a value of USD 3.45 billion by 2035.
The sustained release excipients market forms a crucial component of the pharmaceutical industry, supporting the development of drug formulations that release active ingredients gradually over time. These excipients…
Surgical Tourniquets Market to Reach USD 1.59 Billion by 2035, Growing at 9% CAG …
The surgical tourniquets market is projected to reach USD 670 million by 2025 and is anticipated to grow at a compound annual growth rate (CAGR) of 9%, reaching approximately USD 1,590 million by 2035.
The surgical tourniquets market is an essential segment within the broader medical device industry, focusing on tools that help control blood flow during surgical procedures. These devices, typically used to create a bloodless field in limbs, are…
More Releases for Carbapenem
North America Carbapenem-Based Antibiotics Market Growth Boosting Factors, Chall …
The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it is estimated to grow at a CAGR of 4.7% from 2021-2028.
The latest North America Carbapenem-Based Antibiotics Market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key…
North America Carbapenem-Based Antibiotics Market Size and Growth Opportunities …
The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it is estimated to grow at a CAGR of 4.7% from 2021-2028.
The market's growth is attributed to driving factors such as rising prevalence of bacterial infections and increasing development of generic drugs. However, the tedious and expensive process of the development of antibiotics is expected to restrain the market's…
2021 Carbapenem Market Report- by Leading Manufacturers, its Application and Typ …
Carbapenem Market report also provides supply and demand trends along with an overview of the parent market. Moreover, Carbapenem Market report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current Carbapenem Market forces, and the significant interventions of governments.
Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5023854
By Company
- Pfizer
- Savior Lifetec
- Sun Pharmaceutical Industries
- Kopran
-…
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections i …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii. These…
Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem …
Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 - 2021.
Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of…
Carbapenem-resistant Enterobacteriaceae Testing Market to Partake Significant De …
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii. These…
